Skip to main content
Premium Trial:

Request an Annual Quote

Vimal Mehta, Nasri Nahas, Gregory Phelps

Premium

London-based Inpharmatica has tapped Vimal Mehta as its new senior VP of business development. Previously, Mehta served as senior business development manager at CuraGen, a position he held since 1996. At Inpharmatica, Mehta will lead commercialization efforts for the company’s discovery activities.

Nasri Nahas has been promoted from COO to CEO at Geneva Bioinformatics. Nahas will be charged with launching new products during 2003 and establishing new business operations and partnerships, GeneBio said in a statement. Previously, Nahas held scientific and business positions at Genset and ValiGen.

Ardais of Lexington, Mass., has hired Gregory Phelps as its CEO. Phelps has held executive positions at Baxter Travenol Laboratories, Dyax, and Genzyme. In his most recent position as vice chairman of Dyax, where he will retain his position as director, Phelps executed more than 70 patent and technology licenses and positioned the company for its IPO in 2000.

 

Filed under

The Scan

Highly Similar

Researchers have uncovered bat viruses that are highly similar to SARS-CoV-2, according to Nature News.

Gain of Oversight

According to the Wall Street Journal, the Biden Administration is considering greater oversight of gain-of-function research.

Lasker for mRNA Vaccine Work

The Scientist reports that researchers whose work enabled the development of mRNA-based vaccines are among this year's Lasker Award winners

PLOS Papers on Causal Variant Mapping, Ancient Salmonella, ALK Fusion Test for NSCLC

In PLOS this week: MsCAVIAR approach to map causal variants, analysis of ancient Salmonella, and more.